foxo4-dri cancer The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4-DRI 10mg
FOXO4 DRI 10mg Peptide inhibitors targeting FOXO4 p53 interactions and inducing senescent cancer cell specific apoptosis bioRxiv FOXO4 DRI regulates endothelial cell senescence via the P53 signaling pathway PMC Development of a novel senolytic by precise disruption of FOXO4 p53 complex eBioMedicine FOXO4 DRI For Sale (10mg) Core Peptides FOX04 DRI Apollo Peptide Sciences
Pay in 4 interest-free payments of $6.23 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4





